Delivery Order SPE2DB22D3016-SPE2DB25FBCX3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,169.62 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count). The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $1,049.68. This firm fixed-price delivery order, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.26 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,135,189 units of Dexmethylphenidate ER 10 mg capsules. The $2,805.96 contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.70 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 5 mg capsules (100 count). This competitive award, issued on July 25, 2025, represents a firm fixed price transaction with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dexmethylphenidate ER Capsules 25mg, valued at $4,752.45 under a firm fixed-price contract. This non-set-aside award represents a routine pharmaceutical procurement to support military and federal healthcare operations. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCX3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 5 mg capsules (100-count packaging) with a ceiling value of $2,053.76. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order under a competitively awarded contract with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this prime contract vehicle, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside delivery orders demonstrates its capability to meet federal pharmaceutical procurement requirements and its role as a critical vendor for the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/24/25 |